INTERNATIONAL PATENT: PAUL-EHRLICH-INSTITUT, BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL FILES APPLICATION FOR "TARGETING MAPK-ERK PATHWAY FOR ENHANCING NUCLEIC ACID DELIVERY"

GENEVA, Oct. 27 -- PAUL-EHRLICH-INSTITUT, BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL (Paul-Ehrlich-StraBe 51 - 5963225 Langen) filed a patent application (PCT/EP2025/060735) for "TARGETING MAPK-ERK PATHWAY FOR ENHANCING NUCLEIC ACID DELIVERY" on Apr 17, 2025. With publication no. WO/2025/219572, the details related to the patent application was published on Oct 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): ELHAM, Adabi (Kirdorferstr. 1761350 Bad Homburg), BUCHHOLZ, Christian (Schulstr. 1060594 Frankfurt am Main)

Abstract: The present invention relates to a MAPK-ERK...